Page 3 - Diagnostic Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Growing demand for precision medicine and biomarkers will drive C-reactive protein testing market growth.Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031. Integrating data from diverse sources, such as genetic information, electronic health records, and real-tim

Discover the new cardiology practice at UNC Health Pardee in Pisgah Forest, N.C.

The global burden and death toll of fungi has substantially climbed over the past decade, new research finds. The study estimates that fungal infections help kill nearly 4 million people annually—almost double the amount estimated by similar research in 2012. Co-infections like HIV and tuberculosis, a lack of speedy and reliable diagnostic testing, and growing antifungal resistance are thought to be major contributors to these deaths.

This endocrine case report from Brady Pregerson, MD, features a man in his 40s with a history of T1D presenting with waxing and waning right groin and inner thigh pain. Can you determine the proper diagnosis?

This article looks at how FeNO diagnostics testing is helping those suffering from lung conditions.